Streetbeat News

Analyst Ratings

RVMD

Needham analyst Ami Fadia has reiterated a 'Buy' rating on Revolution Medicines (NASDAQ:RVMD) and maintained a price target of $36.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 11:39 am

DHI

D.R. Horton reported Q4 earnings of $4.45 per share, beating the analyst consensus estimate of $3.93 by 13.23%. However, this is a 4.71% decrease from the same period last year. The company also reported quarterly sales of $10.50 billion, beating the analyst consensus estimate of $10.01 billion by 4.94%, and marking an 8.97% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 11:31 am

COMP

Needham analyst Bernie McTernan has maintained a 'Buy' rating on Compass (NYSE:COMP) but lowered the price target from $4 to $3.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 11:19 am

AYX

Needham analyst Mike Cikos has reiterated a Buy rating on Alteryx (NYSE:AYX) and maintained a $42 price target.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 11:16 am

PAX

Patria Investments (NASDAQ:PAX) reported Q3 earnings of $0.23 per share, missing the analyst consensus estimate of $0.35 by 34.29%. The company also reported quarterly sales of $61.70 million, missing the analyst consensus estimate of $72.85 million by 15.31%. However, both earnings and sales increased compared to the same period last year.

Portfolio Pulse from bharat@benzinga.com

November 07, 2023 | 11:15 am

SIBN

Needham analyst David Saxon has maintained a 'Buy' rating on SI-BONE (NASDAQ:SIBN) but lowered the price target from $32 to $25.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 11:14 am

ATEC

Needham analyst David Saxon has maintained a 'Buy' rating on Alphatec Holdings (NASDAQ:ATEC) but lowered the price target from $20 to $16.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 11:13 am

AZPN

Piper Sandler analyst Clarke Jeffries has reiterated a Neutral rating on Aspen Technology (NASDAQ:AZPN) and maintained a price target of $180.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 11:10 am

EVCM

Piper Sandler analyst Clarke Jeffries has maintained a Neutral rating on EverCommerce (NASDAQ:EVCM) and lowered the price target from $11 to $10.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 11:08 am

OSCR

Oscar Health (NYSE:OSCR) reported Q3 earnings per share of $(0.29), beating the analyst consensus estimate of $(0.51) by 43.14%. This is a 68.13% increase over losses from the same period last year. The company also reported quarterly sales of $1.44 billion, beating the analyst consensus estimate of $1.42 billion by 1.41%, a 47.18% increase over sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 11:06 am